Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally designed for type 2 diabetes management have emerged as one of the most powerful pharmacological tools for sustainable weight reduction
Run 6-8 weeks on, then take 4-6 weeks off
In some cases, switching to a different medication with a different pharmacokinetic profile may improve tolerability
This is a common side effect of the medications impact on the brains reward centers
Future research should aim to address these limitations by enhancing bioavailability through nanotechnology and chemical modifications, exploring multi-target therapies, and investigating the potential of flavonoids in personalized medicine and as antiviral treatments for epilepsy
For instance, Ozempic helps reduce the risk of serious cardiovascular events, such as heart attacks, strokes, and cardiovascular-related deaths, in adults with type 2 diabetes